Style | Citing Format |
---|---|
MLA | Tamardash LK, et al.. "Synthesis, Qsar Modeling, and Molecular Docking Studies of 1,2,3-Triazole-Pyrazole Hybrids As Significant Anti-Cancer and Anti-Microbial Agents." Journal of Molecular Structure, vol. 1335, no. , 2025, pp. -. |
APA | Tamardash LK, Bakherad M, Bakherad H, Jalali F, Keivanloo A, Mozafari Z (2025). Synthesis, Qsar Modeling, and Molecular Docking Studies of 1,2,3-Triazole-Pyrazole Hybrids As Significant Anti-Cancer and Anti-Microbial Agents. Journal of Molecular Structure, 1335(), -. |
Chicago | Tamardash LK, Bakherad M, Bakherad H, Jalali F, Keivanloo A, Mozafari Z. "Synthesis, Qsar Modeling, and Molecular Docking Studies of 1,2,3-Triazole-Pyrazole Hybrids As Significant Anti-Cancer and Anti-Microbial Agents." Journal of Molecular Structure 1335, no. (2025): -. |
Harvard | Tamardash LK et al. (2025) 'Synthesis, Qsar Modeling, and Molecular Docking Studies of 1,2,3-Triazole-Pyrazole Hybrids As Significant Anti-Cancer and Anti-Microbial Agents', Journal of Molecular Structure, 1335(), pp. -. |
Vancouver | Tamardash LK, Bakherad M, Bakherad H, Jalali F, Keivanloo A, Mozafari Z. Synthesis, Qsar Modeling, and Molecular Docking Studies of 1,2,3-Triazole-Pyrazole Hybrids As Significant Anti-Cancer and Anti-Microbial Agents. Journal of Molecular Structure. 2025;1335():-. |
BibTex | @article{ author = {Tamardash LK and Bakherad M and Bakherad H and Jalali F and Keivanloo A and Mozafari Z}, title = {Synthesis, Qsar Modeling, and Molecular Docking Studies of 1,2,3-Triazole-Pyrazole Hybrids As Significant Anti-Cancer and Anti-Microbial Agents}, journal = {Journal of Molecular Structure}, volume = {1335}, number = {}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Tamardash LK AU - Bakherad M AU - Bakherad H AU - Jalali F AU - Keivanloo A AU - Mozafari Z TI - Synthesis, Qsar Modeling, and Molecular Docking Studies of 1,2,3-Triazole-Pyrazole Hybrids As Significant Anti-Cancer and Anti-Microbial Agents JO - Journal of Molecular Structure VL - 1335 IS - SP - EP - PY - 2025 ER - |